Customer Publication

Digital Holographic Microscopy for Non-invasive Monitoring of Cell Cycle Arrest in L929 Cells

Authors: M. Miniotis et al.

Journal: PLOS ONE (2014)

Institution: Malmö University

Research Areas: Method development

Cell Lines: L929 (Mouse fibroblast)

Summary: We show that average cell phase volume results from DHM readings are comparable to the flow cytometry findings. DHM thus provides a non-disruptive alternative to flow cytometry. The technique has the potential to develop into a fast and cost-efficient method for pre-clinical monitoring of cancer treatment efficacy.

Keywords: Holomonitor M3, Cell morphology, Cell cycle and cell division, Flow cytometry, Cancer treatment, G1 phase, Colcemid treatment, Holographic microscopy, therapeutic drug

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.se

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.se

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2